Susan D. Brooks
2 Park Rd
Grafton, AUK 1023, New Zealand
Grafton, AUK 1023, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: January 20, 2023
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation Therapy.
Journal: International journal of radiation oncology, biology, physics
Published: July 14, 2021
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial.
Journal: International journal of radiation oncology, biology, physics
Published: August 27, 2020
Corrigendum: Different Strokes for Different Folks: The BodyMind Approach as a Learning Tool for Patients With Medically Unexplained Symptoms to Self-Manage.
Journal: Frontiers in psychology
Published: July 24, 2019
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial.
Journal: The Lancet. Oncology
Published: March 22, 2019
A retrospective audit of treatment pathway for women diagnosed with cervical cancer in the Auckland region 2012-2016.
Journal: Journal of medical imaging and radiation oncology
Published: February 19, 2019
Medically Unexplained Symptoms and Attachment Theory: The BodyMind Approach®.
Journal: Frontiers in psychology
Published: October 28, 2018
Different Strokes for Different Folks: The BodyMind Approach as a Learning Tool for Patients With Medically Unexplained Symptoms to Self-Manage.
Journal: Frontiers in psychology
Published: April 24, 2018
Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 15, 2017
Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.
Journal: British journal of cancer
Published: April 05, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026